Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study-Reference-Cited by-同舟云学术

Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study

Published:2011-05-27 Issue:7 Volume:20 Page:689-699
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Re Vincent Lo¹²,Lim Joseph K.³⁴,Goetz Matthew Bidwell⁵⁶,Tate Janet³⁴,Bathulapalli Harini³⁴,Klein Marina B.⁷,Rimland David⁸⁹,Rodriguez-Barradas Maria C.¹⁰¹¹,Butt Adeel A.¹²¹³,Gibert Cynthia L.¹⁴¹⁵,Brown Sheldon T.¹⁶¹⁷,Kidwai Farah³⁴,Brandt Cynthia³⁴,Dorey-Stein Zachariah¹²,Reddy K. Rajender¹⁸,Justice Amy C.³⁴

Affiliation:

1. Philadelphia VA Medical Center; Philadelphia PA USA

2. Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania School of Medicine; Philadelphia PA USA

3. VA Connecticut Healthcare System; West Haven CT USA

4. Yale University School of Medicine; New Haven CT USA

5. VA Greater Los Angeles Healthcare System; Los Angeles CA USA

6. David Geffen School of Medicine at UCLA; Los Angeles CA USA

7. Royal Victoria Hospital; McGill University Health Centre; Montreal Quebec Canada

8. Atlanta VA Medical Center; Atlanta GA USA

9. Emory University School of Medicine; Atlanta GA USA

10. Michael E. DeBakey VA Medical Center; Houston TX USA

11. Baylor College of Medicine; Houston TX USA

12. VA Pittsburgh Healthcare System; Pittsburgh PA USA

13. University of Pittsburgh School of Medicine; Pittsburgh PA USA

14. Washington DC VA Medical Center; Washington DC USA

15. George Washington University Medical Center; Washington DC USA

16. James J. Peters VA Medical Center and Mt. Sinai School of Medicine; New York NY USA

17. Mt. Sinai School of Medicine; New York NY USA

18. University of Pennsylvania School of Medicine; Philadelphia PA USA

Funder

National Institute of Allergy and Infectious Diseases

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.2148/fullpdf

Reference35 articles.

1. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients;Benhamou;Hepatology,1999

2. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study;Di Martino;Hepatology,2001

3. Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy;Fuster;AIDS Res Hum Retroviruses,2004

4. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C;Garcia-Samaniego;Am J Gastroenterol,1997

5. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users;Pol;J Hepatol,1998

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rates, patterns, and predictors of specialty palliative care consultation among patients with acute-on-chronic liver failure;JHEP Reports;2024-02

2. Evaluating the predictive performance of the elderly patient calculator TIPS score in a North American cohort;Hepatology Communications;2024-01-22

3. Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin;Research and Practice in Thrombosis and Haemostasis;2024-01

4. Development and validation of a case definition to estimate the prevalence and incidence of cirrhosis in pan-Canadian primary care databases;Canadian Liver Journal;2023-12-20

5. Recent Trends in Palliative Care Utilization in Patients With Decompensated Liver Disease: 2016–2020 National Analysis;Journal of Palliative Medicine;2023-10-18